Researcher.Life Logo

Gene Therapy : Impact Factor & More

eISSN: 1476-5462pISSN: 0969-7128

Key Metrics

CiteScore
7.6
H-Index
169
Impact Factor
5 - 10
SJR
Q1Genetics
SNIP
0.82
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Gene Therapy

Gene Therapy Journal Specifications

Overview
Publisher SPRINGERNATURE
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year1994
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Gene Therapy ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Gene Therapy

A dose-escalation and safety gene therapy study in a model of CMT4C neuropathy.
  • 12 May 2026
  • Gene therapy
Clinical response to systemic AAV gene therapy in a large animal model of late-stage lysosomal storage disease.
  • 4 May 2026
  • Gene therapy
AAV2 capsid clearance and neuronal trafficking dynamics in the central nervous system.
  • 30 Apr 2026
  • Gene therapy
Correction: Genetic mutations in HSV-1 replication-defective vectors: Implications for their safety in gene therapy applications
  • 20 Apr 2026
  • Gene Therapy
Beneficial bystander-enhanced cryptic splice rescue of cardiac-type Fabry GLA IVS4+919G>A by adenine base editing in patient fibroblasts.
  • 18 Apr 2026
  • Gene therapy
Retraction Note: Local administration of transcription factor decoy oligonucleotides to nuclear factor-κB prevents carrageenin-induced inflammation in rat hind paw.
  • 15 Apr 2026
  • Gene therapy
A dose-escalation and safety gene therapy study in a model of CMT4C neuropathy.
  • 12 May 2026
  • Gene therapy
Clinical response to systemic AAV gene therapy in a large animal model of late-stage lysosomal storage disease.
  • 4 May 2026
  • Gene therapy
AAV2 capsid clearance and neuronal trafficking dynamics in the central nervous system.
  • 30 Apr 2026
  • Gene therapy
Correction: Genetic mutations in HSV-1 replication-defective vectors: Implications for their safety in gene therapy applications
  • 20 Apr 2026
  • Gene Therapy
Beneficial bystander-enhanced cryptic splice rescue of cardiac-type Fabry GLA IVS4+919G>A by adenine base editing in patient fibroblasts.
  • 18 Apr 2026
  • Gene therapy
Retraction Note: Local administration of transcription factor decoy oligonucleotides to nuclear factor-κB prevents carrageenin-induced inflammation in rat hind paw.
  • 15 Apr 2026
  • Gene therapy

FAQs on Gene Therapy